Additional file 2: of Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial

Additional file 2: of The effects of corticosteroids on COPD lung macrophages: a pooled analysis

Andrew Higham (3447230)
George Booth (3535088)
Simon Lea (114215)
Thomas Southworth (3535091)
Jonathan Plumb (414289)
Dave Singh (114223)

August 2015

Mean dexamethasone dose response curves comparing COPD current smokers to ex-smokers, ICS users to t...

Additional file 1: of Lung function reductions associated with motor vehicle density in chronic obstructive pulmonary disease: a cross-sectional study

Monika Nitschke (3457571)
Sarah Appleton (3457565)
Qiaoyu Li (3457568)
Graeme Tucker (402091)
Pushan Shah (2173612)
Peng Bi (424140)
Dino Pisaniello (785064)
Robert Adams (77677)

October 2016

Lung function reductions associated with motor vehicle density in chronic obstructive pulmonary dise...

Additional file 2: of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Dave Singh (114223)
Sally Worsley (3573320)
Chang-Qing Zhu (3573326)
Liz Hardaker (3573323)
Alison Church (811460)

August 2015

Study design Figure. Abbreviations: BDI, Baseline Dyspnoea Index; CAT, COPD Assessment Test; FP/SAL,...

Additional file 1: of Association of lung function with cardiovascular risk: a cohort study

Bin Wang (30851)
Yun Zhou (308977)
Lili Xiao (3182601)
Yanjun Guo (446774)
Jixuan Ma (4526053)
Min Zhou (173135)
Tingming Shi (62627)
Aijun Tan (5939990)
Jing Yuan (217967)
Weihong Chen (170472)

November 2018

Table S1. Ten-Year CVD Risk by GOLD classification and selected baseline characteristics in COPD pat...

Additional file 1: of Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review

Marc Miravitlles (528052)
Anthony DâUrzo (3447389)
Dave Singh (114223)
Vladimir Koblizek (656454)

September 2016

Supplementary material. Table S1. Comparison of guidelines and recommendations definitions of exacer...

Additional file 2: of Lower mortality after early supervised pulmonary rehabilitation following COPD-exacerbations: a systematic review and meta-analysis

Camilla RyrsĂ¸ (5751188)
Nina Godtfredsen (5245451)
Linette Kofod (5751167)
Marie Lavesen (5751170)
Line Mogensen (5751173)
Randi Tobberup (5751176)
Ingeborg Farver-Vestergaard (3242601)
Henriette Callesen (5751179)
Britta Tendal (5751182)
Peter Lange (2969898)
Ulrik Iepsen (5751185)

September 2018

AGREE II. A critical group appraisal of: Pulmonary rehabilitation for patients with chronic pulmonar...

Additional file 1: of Risk of acute exacerbations in chronic obstructive pulmonary disease associated with biomass smoke compared with tobacco smoke

Jaeyoung Cho (3353363)
Chang-Hoon Lee (196719)
Seung-sik Hwang (286891)
Ki Uk Kim (3168096)
Sang Haak Lee (669846)
Hye Yun Park (404092)
Seoung Ju Park (6500843)
Kyung Hoon Min (799720)
Yeon-Mok Oh (709680)
Kwang Ha Yoo (709681)
Ki-Suck Jung (2817685)

March 2019

Online supplement (DOC). Figure S1. Histograms showing propensity score distribution. Table S1. Base...

Additional file 2: of Long-term outcomes following first short-term clinically important deterioration in COPD

Ian Naya (4013171)
Lee Tombs (4774074)
Hana Muellerova (5990843)
Christopher Compton (5990852)
Paul Jones (1523707)

November 2018

Table S1. Patient demographics and baseline characteristics (ECLIPSE study). Table S2. Long-term out...

Additional file 1: Table S1. of Multiple biomarkers predict disease severity, progression and mortality in COPD

Rachel Zemans (4108111)
Sean Jacobson (2993688)
Jason Keene (4108108)
Katerina Kechris (436022)
Bruce Miller (695078)
Ruth Tal-Singer (164946)
Russell Bowler (3471647)

June 2017

Association Between Biomarkers and COPD Outcomes. Table S2. Statistical Models. Table S3. Demographi...

Additional file 1: of Importance of the relationship between symptoms and self-reported physical activity level in stable COPD based on the results from the SPACE study

Florin Mihaltan (6701033)
Yochai Adir (6701036)
Adam Antczak (617966)
Konstantinos Porpodis (6701039)
Vesna Radulovic (6701042)
Nuno Pires (587736)
Geeuwke Vries (6701045)
Andreas Horner (292518)
Samuel Bontridder (6701048)
Yunqin Chen (728517)
Anat Shavit (6701051)
Silviu Alecu (6701057)
Lukasz Adamek (6701060)

May 2019

Table S1. Main COPD treatment patterns by therapeutic classes, irrespective of other maintenance tre...

Additional file 1 of Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands

Karin M. A. Swart (3752983)
Brenda N. Baak (10884503)
Louise Lemmens (17429451)
Fernie J. A. Penning-van Beest (17429454)
Camilla Bengtsson (60655)
Muriel Lobier (399321)
Fabian Hoti (4799283)
Dina Vojinovic (5410805)
Lindy van Burk (17429457)
Kirsty Rhodes (11184558)
Edeltraut Garbe (182117)
Ron M. C. Herings (4601446)
Clementine Nordon (2285455)
Sami O. Simons (13018809)

November 2023

Additional file 1: Figure S1. Flowchart of patient selection. Table S1. Codes used for identificatio...

Additional file 1: of Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort

Hye Park (3485240)
Suh-Young Lee (578553)
Danbee Kang (4683472)
Juhee Cho (164532)
Hyun Lee (468713)
Seong Lim (4055431)
Ho Yoon (3745087)
Seung Ra (4055062)
Ki Kim (3021105)
Yeon-Mok Oh (709680)
Don Sin (128552)
Sang-Do Lee (730571)
Yong Park (583109)

March 2018

Table S1. The component distribution of ACO. Table S2. Longitudinal change of annual forced expirato...

Additional file 2: Figure S1. of Multiple biomarkers predict disease severity, progression and mortality in COPD

Rachel Zemans (4108111)
Sean Jacobson (2993688)
Jason Keene (4108108)
Katerina Kechris (436022)
Bruce Miller (695078)
Ruth Tal-Singer (164946)
Russell Bowler (3471647)

June 2017

Distribution of Biomarkers. Biomarker levels were log transformed. Figure S2. Relationship Between I...

Additional file 1: Table S1. of Expiratory central airway collapse in stable COPD and during exacerbations

Paul Leong (2230297)
Anne Tran (617261)
Jhanavi Rangaswamy (4393879)
Laurence Ruane (4393873)
Michael Fernando (4393870)
Martin MacDonald (4393867)
Kenneth Lau (119228)
Philip Bardin (4393876)

August 2017

Comparison of patients with AECOPD with and without ECAC (ECAC diagnosed by 75% area reduction thres...

Additional file 2: of A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease

Maggie Tabberer (508226)
Jean Brooks (811459)
Teresa Wilcox (3475958)

October 2015

Schematic of the study design used in each of the four included studies. *Studies DB2113361 [11] and...

Additional file 2: of The effects of corticosteroids on COPD lung macrophages: a pooled analysis

Andrew Higham (3447230)
George Booth (3535088)
Simon Lea (114215)
Thomas Southworth (3535091)
Jonathan Plumb (414289)
Dave Singh (114223)

August 2015

Mean dexamethasone dose response curves comparing COPD current smokers to ex-smokers, ICS users to t...

Additional file 1: of Lung function reductions associated with motor vehicle density in chronic obstructive pulmonary disease: a cross-sectional study

Monika Nitschke (3457571)
Sarah Appleton (3457565)
Qiaoyu Li (3457568)
Graeme Tucker (402091)
Pushan Shah (2173612)
Peng Bi (424140)
Dino Pisaniello (785064)
Robert Adams (77677)

October 2016

Lung function reductions associated with motor vehicle density in chronic obstructive pulmonary dise...

Additional file 2: of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Dave Singh (114223)
Sally Worsley (3573320)
Chang-Qing Zhu (3573326)
Liz Hardaker (3573323)
Alison Church (811460)

August 2015

Study design Figure. Abbreviations: BDI, Baseline Dyspnoea Index; CAT, COPD Assessment Test; FP/SAL,...

Additional file 1: of Association of lung function with cardiovascular risk: a cohort study

Bin Wang (30851)
Yun Zhou (308977)
Lili Xiao (3182601)
Yanjun Guo (446774)
Jixuan Ma (4526053)
Min Zhou (173135)
Tingming Shi (62627)
Aijun Tan (5939990)
Jing Yuan (217967)
Weihong Chen (170472)

November 2018

Table S1. Ten-Year CVD Risk by GOLD classification and selected baseline characteristics in COPD pat...

Additional file 1: of Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review

Marc Miravitlles (528052)
Anthony DâUrzo (3447389)
Dave Singh (114223)
Vladimir Koblizek (656454)

September 2016

Supplementary material. Table S1. Comparison of guidelines and recommendations definitions of exacer...

Additional file 2: of Lower mortality after early supervised pulmonary rehabilitation following COPD-exacerbations: a systematic review and meta-analysis

Camilla RyrsĂ¸ (5751188)
Nina Godtfredsen (5245451)
Linette Kofod (5751167)
Marie Lavesen (5751170)
Line Mogensen (5751173)
Randi Tobberup (5751176)
Ingeborg Farver-Vestergaard (3242601)
Henriette Callesen (5751179)
Britta Tendal (5751182)
Peter Lange (2969898)
Ulrik Iepsen (5751185)

September 2018

AGREE II. A critical group appraisal of: Pulmonary rehabilitation for patients with chronic pulmonar...

Additional file 1: of Risk of acute exacerbations in chronic obstructive pulmonary disease associated with biomass smoke compared with tobacco smoke

Jaeyoung Cho (3353363)
Chang-Hoon Lee (196719)
Seung-sik Hwang (286891)
Ki Uk Kim (3168096)
Sang Haak Lee (669846)
Hye Yun Park (404092)
Seoung Ju Park (6500843)
Kyung Hoon Min (799720)
Yeon-Mok Oh (709680)
Kwang Ha Yoo (709681)
Ki-Suck Jung (2817685)

March 2019

Online supplement (DOC). Figure S1. Histograms showing propensity score distribution. Table S1. Base...

Additional file 2: of Long-term outcomes following first short-term clinically important deterioration in COPD

Ian Naya (4013171)
Lee Tombs (4774074)
Hana Muellerova (5990843)
Christopher Compton (5990852)
Paul Jones (1523707)

November 2018

Table S1. Patient demographics and baseline characteristics (ECLIPSE study). Table S2. Long-term out...

Additional file 1: Table S1. of Multiple biomarkers predict disease severity, progression and mortality in COPD

Rachel Zemans (4108111)
Sean Jacobson (2993688)
Jason Keene (4108108)
Katerina Kechris (436022)
Bruce Miller (695078)
Ruth Tal-Singer (164946)
Russell Bowler (3471647)

June 2017

Association Between Biomarkers and COPD Outcomes. Table S2. Statistical Models. Table S3. Demographi...

Additional file 1: of Importance of the relationship between symptoms and self-reported physical activity level in stable COPD based on the results from the SPACE study

Florin Mihaltan (6701033)
Yochai Adir (6701036)
Adam Antczak (617966)
Konstantinos Porpodis (6701039)
Vesna Radulovic (6701042)
Nuno Pires (587736)
Geeuwke Vries (6701045)
Andreas Horner (292518)
Samuel Bontridder (6701048)
Yunqin Chen (728517)
Anat Shavit (6701051)
Silviu Alecu (6701057)
Lukasz Adamek (6701060)

May 2019

Table S1. Main COPD treatment patterns by therapeutic classes, irrespective of other maintenance tre...

Additional file 1 of Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands

Karin M. A. Swart (3752983)
Brenda N. Baak (10884503)
Louise Lemmens (17429451)
Fernie J. A. Penning-van Beest (17429454)
Camilla Bengtsson (60655)
Muriel Lobier (399321)
Fabian Hoti (4799283)
Dina Vojinovic (5410805)
Lindy van Burk (17429457)
Kirsty Rhodes (11184558)
Edeltraut Garbe (182117)
Ron M. C. Herings (4601446)
Clementine Nordon (2285455)
Sami O. Simons (13018809)

November 2023

Additional file 1: Figure S1. Flowchart of patient selection. Table S1. Codes used for identificatio...

Additional file 1: of Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort

Hye Park (3485240)
Suh-Young Lee (578553)
Danbee Kang (4683472)
Juhee Cho (164532)
Hyun Lee (468713)
Seong Lim (4055431)
Ho Yoon (3745087)
Seung Ra (4055062)
Ki Kim (3021105)
Yeon-Mok Oh (709680)
Don Sin (128552)
Sang-Do Lee (730571)
Yong Park (583109)

March 2018

Table S1. The component distribution of ACO. Table S2. Longitudinal change of annual forced expirato...

Additional file 2: Figure S1. of Multiple biomarkers predict disease severity, progression and mortality in COPD

Rachel Zemans (4108111)
Sean Jacobson (2993688)
Jason Keene (4108108)
Katerina Kechris (436022)
Bruce Miller (695078)
Ruth Tal-Singer (164946)
Russell Bowler (3471647)

June 2017

Distribution of Biomarkers. Biomarker levels were log transformed. Figure S2. Relationship Between I...

Additional file 1: Table S1. of Expiratory central airway collapse in stable COPD and during exacerbations

Paul Leong (2230297)
Anne Tran (617261)
Jhanavi Rangaswamy (4393879)
Laurence Ruane (4393873)
Michael Fernando (4393870)
Martin MacDonald (4393867)
Kenneth Lau (119228)
Philip Bardin (4393876)

August 2017

Comparison of patients with AECOPD with and without ECAC (ECAC diagnosed by 75% area reduction thres...

Additional file 2: of A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease

Maggie Tabberer (508226)
Jean Brooks (811459)
Teresa Wilcox (3475958)

October 2015

Schematic of the study design used in each of the four included studies. *Studies DB2113361 [11] and...

Additional file 2: of The effects of corticosteroids on COPD lung macrophages: a pooled analysis

Andrew Higham (3447230)
George Booth (3535088)
Simon Lea (114215)
Thomas Southworth (3535091)
Jonathan Plumb (414289)
Dave Singh (114223)

August 2015

Mean dexamethasone dose response curves comparing COPD current smokers to ex-smokers, ICS users to t...

Additional file 1: of Lung function reductions associated with motor vehicle density in chronic obstructive pulmonary disease: a cross-sectional study

Monika Nitschke (3457571)
Sarah Appleton (3457565)
Qiaoyu Li (3457568)
Graeme Tucker (402091)
Pushan Shah (2173612)
Peng Bi (424140)
Dino Pisaniello (785064)
Robert Adams (77677)

October 2016

Lung function reductions associated with motor vehicle density in chronic obstructive pulmonary dise...

Additional file 2: of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Dave Singh (114223)
Sally Worsley (3573320)
Chang-Qing Zhu (3573326)
Liz Hardaker (3573323)
Alison Church (811460)

August 2015

Study design Figure. Abbreviations: BDI, Baseline Dyspnoea Index; CAT, COPD Assessment Test; FP/SAL,...

Additional file 2: of Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial

Abstract

Extracted data

Additional file 2: of Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial

Abstract

Extracted data

Related items

Related items